Practice guideline: Treatment for insomnia and disrupted sleep behavior in children and adolescents with autism spectrum disorder: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.
Journal
Neurology
ISSN: 1526-632X
Titre abrégé: Neurology
Pays: United States
ID NLM: 0401060
Informations de publication
Date de publication:
03 03 2020
03 03 2020
Historique:
received:
12
04
2019
accepted:
09
12
2019
pubmed:
14
2
2020
medline:
15
7
2020
entrez:
14
2
2020
Statut:
ppublish
Résumé
To review pharmacologic and nonpharmacologic strategies for treating sleep disturbances in children and adolescents with autism spectrum disorder (ASD) and to develop recommendations for addressing sleep disturbance in this population. The guideline panel followed the American Academy of Neurology 2011 guideline development process, as amended. The systematic review included studies through December 2017. Recommendations were based on evidence, related evidence, principles of care, and inferences. For children and adolescents with ASD and sleep disturbance, clinicians should assess for medications and coexisting conditions that could contribute to the sleep disturbance and should address identified issues. Clinicians should counsel parents regarding strategies for improved sleep habits with behavioral strategies as a first-line treatment approach for sleep disturbance either alone or in combination with pharmacologic or nutraceutical approaches. Clinicians should offer melatonin if behavioral strategies have not been helpful and contributing coexisting conditions and use of concomitant medications have been addressed, starting with a low dose. Clinicians should recommend using pharmaceutical-grade melatonin if available. Clinicians should counsel children, adolescents, and parents regarding potential adverse effects of melatonin use and the lack of long-term safety data. Clinicians should counsel that there is currently no evidence to support the routine use of weighted blankets or specialized mattress technology for improving disrupted sleep. If asked about weighted blankets, clinicians should counsel that the trial reported no serious adverse events with blanket use and that blankets could be a reasonable nonpharmacologic approach for some individuals.
Identifiants
pubmed: 32051244
pii: WNL.0000000000009033
doi: 10.1212/WNL.0000000000009033
pmc: PMC7238942
doi:
Types de publication
Journal Article
Practice Guideline
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
392-404Subventions
Organisme : NICHD NIH HHS
ID : P50 HD093074
Pays : United States
Commentaires et corrections
Type : CommentIn
Informations de copyright
© 2020 American Academy of Neurology.
Références
J Pineal Res. 2009 Aug;47(1):1-7
pubmed: 19486273
Am J Ment Defic. 1985 Mar;89(5):485-91
pubmed: 3993694
J Paediatr Child Health. 2015 Jun;51(6):584-9
pubmed: 25643981
Child Care Health Dev. 2004 Mar;30(2):139-50
pubmed: 14961866
Pediatrics. 2012 Nov;130 Suppl 2:S139-44
pubmed: 23118244
J Clin Sleep Med. 2017 Jan 15;13(1):95-104
pubmed: 27784416
J Pediatr Psychol. 2008 Apr;33(3):323-32
pubmed: 18003650
J Clin Psychol. 2010 Nov;66(11):1205-15
pubmed: 20865769
Res Dev Disabil. 2014 Jul;35(7):1631-8
pubmed: 24780146
Dev Med Child Neurol. 2014 Aug;56(8):717-23
pubmed: 24575840
Psychopharmacology (Berl). 2010 Oct;212(3):379-91
pubmed: 20668840
Pediatrics. 2007 Nov;120(5):1020-9
pubmed: 17974739
Psychiatry Res. 2012 May 30;197(3):275-9
pubmed: 22365274
Clin Psychol Rev. 2005 Jul;25(5):629-44
pubmed: 15953666
J Sleep Res. 2012 Dec;21(6):700-9
pubmed: 22616853
Paediatr Child Health. 2012 Jun;17(6):331-6
pubmed: 23730172
Res Dev Disabil. 2004 Jan-Feb;25(1):57-66
pubmed: 14733976
Pediatrics. 2012 Nov;130 Suppl 2:S106-24
pubmed: 23118242
Scand J Public Health. 2012 Dec;40(8):704-11
pubmed: 23108475
J Paediatr Child Health. 1998 Dec;34(6):528-33
pubmed: 9928644
Public Health Nurs. 2008 Mar-Apr;25(2):106-14
pubmed: 18294179
J Autism Dev Disord. 2014 Jan;44(1):216-28
pubmed: 23754339
Sleep. 2000 Dec 15;23(8):1043-51
pubmed: 11145319
Nat Sci Sleep. 2017 May 19;9:151-161
pubmed: 28579842
Psychopharmacology (Berl). 2011 Jul;216(1):111-20
pubmed: 21340475
Curr Med Chem. 2013;20(15):2017-31
pubmed: 23410151
J Am Acad Child Adolesc Psychiatry. 2017 Nov;56(11):948-957.e4
pubmed: 29096777
Sleep. 2005 Dec;28(12):1561-7
pubmed: 16408416
J Pediatr Psychol. 2008 May;33(4):380-6
pubmed: 18250091
J Autism Dev Disord. 2012 Apr;42(4):531-8
pubmed: 21538171
Sleep Med. 2013 Oct;14(10):995-1004
pubmed: 23993773
J Neurodev Disord. 2014;6(1):44
pubmed: 25530819
J Clin Sleep Med. 2017 Feb 15;13(2):275-281
pubmed: 27855744
Front Psychiatry. 2019 Jun 06;10:366
pubmed: 31244687
Arch Pediatr Adolesc Med. 2010 Jul;164(7):608-14
pubmed: 20603459
Eur J Paediatr Neurol. 2015 Mar;19(2):122-33
pubmed: 25553845
Pediatrics. 2014 Aug;134(2):298-306
pubmed: 25022743
Dev Med Child Neurol. 1999 Jan;41(1):60-6
pubmed: 10068053
Pediatr Clin North Am. 2011 Jun;58(3):685-98
pubmed: 21600349
J Autism Dev Disord. 2011 Feb;41(2):175-84
pubmed: 20535539
Sleep. 2007 Dec;30(12):1698-703
pubmed: 18246979
Curr Sleep Med Rep. 2015 Jun;1(2):131-140
pubmed: 26046012
Pediatrics. 2003 Oct;112(4):870-7
pubmed: 14523179